247 related articles for article (PubMed ID: 21693435)
1. cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Tham KY; Mastrandrea NJ; Gallegos AC; Monks TJ; Lau SS
Toxicol Sci; 2011 Aug; 122(2):361-71. PubMed ID: 21693435
[TBL] [Abstract][Full Text] [Related]
2. ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Gard JM; Nagle RB; Dietrich JD; Monks TJ; Lau SS
Toxicol Sci; 2011 Nov; 124(1):75-87. PubMed ID: 21813464
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Labenski M; Mastrandrea NJ; Canatsey RD; Monks TJ; Lau SS
Mol Carcinog; 2016 Aug; 55(8):1243-50. PubMed ID: 26333016
[TBL] [Abstract][Full Text] [Related]
4. Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells.
Yoon HS; Ramachandiran S; Chacko MA; Monks TJ; Lau SS
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F417-24. PubMed ID: 14612383
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.
Ambrosini G; Cheema HS; Seelman S; Teed A; Sambol EB; Singer S; Schwartz GK
Mol Cancer Ther; 2008 Apr; 7(4):890-6. PubMed ID: 18413802
[TBL] [Abstract][Full Text] [Related]
6. Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis-2 tumor suppressor gene.
Yoon HS; Monks TJ; Walker CL; Lau SS
Mol Carcinog; 2001 May; 31(1):37-45. PubMed ID: 11398196
[TBL] [Abstract][Full Text] [Related]
7. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
Patel SK; Ma N; Monks TJ; Lau SS
Mol Carcinog; 2003 Nov; 38(3):141-54. PubMed ID: 14587099
[TBL] [Abstract][Full Text] [Related]
8. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat.
Habib SL; Phan MN; Patel SK; Li D; Monks TJ; Lau SS
Carcinogenesis; 2003 Mar; 24(3):573-82. PubMed ID: 12663520
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity.
Yoon HS; Monks TJ; Everitt JI; Walker CL; Lau SS
Am J Physiol Renal Physiol; 2002 Aug; 283(2):F262-70. PubMed ID: 12110509
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells.
Yamaguchi T; Reif GA; Calvet JP; Wallace DP
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F944-51. PubMed ID: 20810616
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.
Lee N; Woodrum CL; Nobil AM; Rauktys AE; Messina MP; Dabora SL
BMC Pharmacol; 2009 Apr; 9():8. PubMed ID: 19368729
[TBL] [Abstract][Full Text] [Related]
12. AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27.
Short JD; Houston KD; Dere R; Cai SL; Kim J; Johnson CL; Broaddus RR; Shen J; Miyamoto S; Tamanoi F; Kwiatkowski D; Mills GB; Walker CL
Cancer Res; 2008 Aug; 68(16):6496-506. PubMed ID: 18701472
[TBL] [Abstract][Full Text] [Related]
13. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
14. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent.
Karbowniczek M; Cash T; Cheung M; Robertson GP; Astrinidis A; Henske EP
J Biol Chem; 2004 Jul; 279(29):29930-7. PubMed ID: 15150271
[TBL] [Abstract][Full Text] [Related]
15. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
16. LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.
Duong MT; Akli S; Wei C; Wingate HF; Liu W; Lu Y; Yi M; Mills GB; Hunt KK; Keyomarsi K
PLoS Genet; 2012; 8(3):e1002538. PubMed ID: 22479189
[TBL] [Abstract][Full Text] [Related]
17. D1 dopamine receptor regulation of the levels of the cell-cycle-controlling proteins, cyclin D, P27 and Raf-1, in cerebral cortical precursor cells is mediated through cAMP-independent pathways.
Zhang L; Bai J; Undie AS; Bergson C; Lidow MS
Cereb Cortex; 2005 Jan; 15(1):74-84. PubMed ID: 15238444
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.
Spirli C; Morell CM; Locatelli L; Okolicsanyi S; Ferrero C; Kim AK; Fabris L; Fiorotto R; Strazzabosco M
Hepatology; 2012 Dec; 56(6):2363-74. PubMed ID: 22653837
[TBL] [Abstract][Full Text] [Related]
19. Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients.
Habib SL
Mol Cancer; 2009 Mar; 8():13. PubMed ID: 19265534
[TBL] [Abstract][Full Text] [Related]
20. Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.
McCampbell AS; Mittelstadt ML; Dere R; Kim S; Zhou L; Djordjevic B; Soliman PT; Zhang Q; Wei C; Hursting SD; Lu KH; Broaddus RR; Walker CL
Curr Mol Med; 2016; 16(3):252-65. PubMed ID: 26917264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
